Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

NG2 is crucial for normal skin and hair development in mice.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Anti-CD19 therapy may help treat SLE and NMOSD.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

EGFR inhibitors for lung cancer can cause severe skin issues.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Touch dome keratinocytes in adult skin have traits of different skin cell types.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Entospletinib effectively prevents eye and skin GVHD in mice.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.